Heparan Sulphate Fragments as Biomarkers of Endothelial Injury in Early Sepsis: A Prospective Cohort Study
DOI:
https://doi.org/10.5281/zenodo.22644085Keywords:
endothelial glycocalyx, heparan sulphate, syndecan-1, sepsis biomarkers, septic shock outcomesAbstract
Background: The endothelial glycocalyx, a heparan sulphate-rich layer coating the vascular lumen, undergoes rapid enzymatic and
proteolytic shedding during sepsis, releasing soluble heparan sulphate fragments and syndecan-1 ectodomain into the circulation.
Objective: This narrative review synthesizes published clinical and mechanistic literature on heparan sulphate and syndecan-1 as
biomarkers of endothelial injury in sepsis. Methods: We reviewed prospective cohort studies, trial substudies, and meta-analyses
reporting circulating glycocalyx degradation products in relation to sepsis severity, organ dysfunction, mortality, and resuscitation
practice. Findings: Circulating syndecan-1 rises in graded fashion with sepsis severity and correlates with coagulopathy,
thrombocytopenia, and respiratory and multi-organ dysfunction; independent meta-analyses spanning thousands of patients
confirm consistent associations between elevated syndecan-1 and mortality, septic shock, and acute kidney injury; large
trial-embedded cohorts further show that glycocalyx degradation predicts outcome independent of randomized fluid strategy,
while the causal contribution of resuscitation volume to shedding remains incompletely resolved. Conclusions: Heparan sulphate
fragments and syndecan-1 are reproducible, mechanistically grounded biomarkers of endothelial injury in sepsis with
demonstrated prognostic value, positioning them as candidates for future risk-stratification and glycocalyx-protective
resuscitation research.
References
Reitsma S, Slaaf DW, Vink H, van Zandvoort MAMJ, oude Egbrink MGA (2007) The endothelial glycocalyx: composition, functions, and visualization. Pflügers Archiv - European Journal of Physiology, 454(3):345-359, DOI:10.1007/s00424-007-0212-8.
Uchimido R, Schmidt EP, Shapiro NI (2019) The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Critical Care, 23:16, DOI:10.1186/s13054-018-2292-6.
Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, Adembri C (2015) Glycocalyx and sepsis-induced alterations in vascular permeability. Critical Care, 19:26, DOI:10.1186/s13054-015-0741-z.
Burke-Gaffney A, Evans TW (2012) Lest we forget the endothelial glycocalyx in sepsis. Critical Care, 16:121, DOI:10.1186/cc11239.
Sallisalmi M, Tenhunen J, Kultti A, Tammi M, Pettilä V (2014) Plasma hyaluronan and hemorheology in patients with septic shock: a clinical and experimental study. Clinical Hemorheology and Microcirculation, 56(2):133-144, DOI:10.3233/CH-131677.
Suzuki K, Okada H, Sumi K, Tomita H, Kobayashi R, Ishihara T, Kakino Y, Suzuki K, Yoshiyama N, Yasuda R, Kitagawa Y, Fukuta T, Miyake T, Okamoto H, Doi T, Yoshida T, Yoshida S, Ogura S, Suzuki A (2021) Serum syndecan-1 reflects organ dysfunction in critically ill patients. Scientific Reports, 11:8864, DOI:10.1038/s41598-021-88303-7.
Zhou G, Liu J, Zhang H, Wang X, Liu D (2022) Elevated endothelial dysfunction-related biomarker levels indicate the severity and predict sepsis incidence. Scientific Reports, 12:21935, DOI:10.1038/s41598-022-26623-y.
Ostrowski SR, Haase N, Müller RB, Møller MH, Pott FC, Perner A, Johansson PI (2015) Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Critical Care, 19:191, DOI:10.1186/s13054-015-0918-5.
Hatanaka K, Ito T, Madokoro Y, Kamikokuryo C, Niiyama S, Yamada S, Maruyama I, Kakihana Y (2021) Circulating syndecan-1 as a predictor of persistent thrombocytopenia and lethal outcome: a population study of patients with suspected sepsis requiring intensive care. Frontiers in Cardiovascular Medicine, 8:730553, DOI:10.3389/fcvm.2021.730553.
Smart L, Bosio E, Macdonald SPJ, Dull R, Fatovich DM, Neil C, Arendts G (2018) Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan. Journal of Critical Care, 47:93-98, DOI:10.1016/j.jcrc.2018.06.015.
Kajita Y, Terashima T, Mori H, Islam MM, Irahara T, Tsuda M, Kano H, Takeyama N (2021) A longitudinal change of syndecan-1 predicts risk of acute respiratory distress syndrome and cumulative fluid balance in patients with septic shock: a preliminary study. Journal of Intensive Care, 9:27, DOI:10.1186/s40560-021-00543-x.
Sun T, Wang Y, Wu X, Cai Y, Zhai T, Zhan Q (2022) Prognostic value of syndecan-1 in the prediction of sepsis-related complications and mortality: a meta-analysis. Frontiers in Public Health, 10:870065, DOI:10.3389/fpubh.2022.870065.
Fernández-Sarmiento J, Molina CF, Salazar-Pelaez LM, Flórez S, Alarcón-Forero LC, Sarta M, Hernández-Sarmiento R, Villar JC (2023) Biomarkers of glycocalyx injury and endothelial activation are associated with clinical outcomes in patients with sepsis: a systematic review and meta-analysis. Journal of Intensive Care Medicine, 38(1):95-105, DOI:10.1177/08850666221109186.
Piotti A, Novelli D, Meessen JMTA, Ferlicca D, Coppolecchia S, Marino A, Salati G, Savioli M, Grasselli G, Bellani G, Pesenti A, Masson S, Caironi P, Gattinoni L, Gobbi M, Fracasso C, Latini R; ALBIOS Investigators (2021) Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Critical Care, 25:113, DOI:10.1186/s13054-021-03545-1.
Oshima K, Di Gravio C, Yan B, McMurtry SA, Burke R, Levoir LM, Kravitz MS, Stephenson D, Issaian A, Hansen KC, D'Alessandro A, Douglas IS, Self WH, Lindsell CJ, Schildcrout JS, Schmidt EP, Shapiro NI (2025) Endothelial glycocalyx degradation in sepsis: analysis of the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial, a multicenter, phase 3, randomized trial. Annals of the American Thoracic Society, 22(9):1382-1393, DOI:10.1513/AnnalsATS.202501-012OC.
Hippensteel JA, Uchimido R, Tyler PD, Burke RC, Han X, Zhang F, McMurtry SA, Colbert JF, Lindsell CJ, Angus DC, Kellum JA, Yealy DM, Linhardt RJ, Shapiro NI, Schmidt EP (2019) Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Critical Care, 23:259, DOI:10.1186/s13054-019-2534-2.
Macdonald S, Bosio E, Shapiro NI, Balmer L, Burrows S, Hibbs M, Jowitt T, Smart L, Arendts G, Fatovich D (2022) No association between intravenous fluid volume and endothelial glycocalyx shedding in patients undergoing resuscitation for sepsis in the emergency department. Scientific Reports, 12:8733, DOI:10.1038/s41598-022-12752-x.
Sallee CJ, Noa AS, Bhowmik M, Nobles AC, Wang Z, Liu J, Richter JR, Blalock JE, Patel RP, Gaggar A, Richter RP (2026) Age-related differences in circulating heparanase-1 activity in sepsis and correlation with systemic vascular endotheliopathy. Frontiers in Medicine, 13:1893157, DOI:10.3389/fmed.2026.1893157.
Saavedra-Torres JS, Acosta Castillo LV, Montoya Rendon A, Castro Valencia DE, Lucero Guanga DA, Garzon Ovalle M, Arias Rodríguez FD, López-Cortés A, Izquierdo-Condoy JS (2026) From glycocalyx shedding to microvascular collapse in sepsis: endothelial pathophysiology, organ dysfunction, and mechanistic biomarkers. Pathophysiology, 33(2):36, DOI:10.3390/pathophysiology33020036.
